| Drug Name |
Raltegravir potassium |
| Drug ID |
BADD_D01906 |
| Description |
Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. |
| Indications and Usage |
For the treatment of HIV-1 infection in conjunction with other antiretrovirals. |
| Marketing Status |
approved |
| ATC Code |
J05AJ01 |
| DrugBank ID |
DB06817
|
| KEGG ID |
D07133
|
| MeSH ID |
D000068898
|
| PubChem ID |
23668479
|
| TTD Drug ID |
D0I1FQ
|
| NDC Product Code |
62331-055; 67317-0001; 67651-0275; 70600-028; 50473-0001; 67317-0031; 65977-0129; 67651-0276; 65015-841; 67651-0274 |
| UNII |
43Y000U234
|
| Synonyms |
Raltegravir Potassium | Potassium, Raltegravir | Raltegravir | MK 0518 | 0518, MK | MK0518 | MK-0518 | Isentress |
